miRNA-155 controls mast cell activation by regulating the PI3Kγ pathway and anaphylaxis in a mouse model

K Biethahn1, Z Orinska, E Vigorito

  • 1Research Center Borstel, Borstel, Germany.

Allergy
|April 17, 2014
PubMed
Abstract

Insights

MicroRNA-155 (miR-155) deficiency enhances mast cell degranulation and allergic reactions by modulating the PI3Kγ pathway. This suggests miR-155 is a critical regulator of mast cell activation in allergic disorders.

Area of Science:

  • Immunology
  • Molecular Biology
  • Cell Signaling

Background:

  • Mast cells (MCs) are key players in allergic and inflammatory responses, mediating reactions through degranulation upon FcεRI activation.
  • Phosphoinositide-3-kinase (PI3K) signaling pathways are crucial for MC activation.
  • MicroRNAs (miRNAs) are emerging as regulators of PI3K/Akt signaling.

Purpose of the Study:

  • To investigate the role of microRNA-155 (miR-155) in regulating mast cell (MC) function and allergic responses.
  • To elucidate the molecular mechanisms by which miR-155 influences MC activation via the PI3K pathway.

Main Methods:

  • Utilized a passive cutaneous anaphylaxis (PCA) mouse model to study MC-dependent allergic reactions in wild-type (WT) and miR-155 knockout (miR-155(-/-)) mice.
  • Compared WT and miR-155(-/-) bone marrow-derived mast cells (BMMCs) to analyze FcεRI-mediated degranulation and mediator release.
  • Assessed Akt phosphorylation and gene expression of PI3K isoforms in BMMCs.

Main Results:

  • miR-155(-/-) mice exhibited enhanced anaphylaxis reactions compared to WT mice.
  • miR-155 deficiency in BMMCs led to increased FcεRI-mediated degranulation and release of inflammatory cytokines (TNF-α, IL-13, IL-6).
  • Increased Akt phosphorylation and elevated expression of PI3Kγ subunits (Pik3r5, Pik3r6) were observed in miR-155(-/-) BMMCs, with PI3Kγ pathway blockade inhibiting degranulation.

Conclusions:

  • miR-155 negatively regulates FcεRI-mediated mast cell responses by modulating components of the PI3Kγ pathway.
  • This study identifies a novel miRNA-dependent mechanism controlling mast cell activation, potentially impacting allergic disease development and progression.